Gout: Introduction FeedbackA general introduction to Gout.Source: Clinical Knowledge Summaries, 01 Aug 2012
Gout is a disorder of purine metabolism characterized by a raised uric acid level in the blood (hyperuricaemia) and the deposition of urate crystals in joints and other tissues.
The natural history of gout can occur in three distinct phases:
A long period of asymptomatic hyperuricaemia.
A period during which acute attacks of gouty arthritis are followed by variable intervals (months to years) when there are no symptoms.
The final period of chronic tophaceous gout where people have nodules affecting joints.
Hyperuricaemia is the single most important risk factor for developing gout.
Gout is more common in men and in older people. Only 3–6% of people with gout have onset of the disease before 25 years of age.
Hyperuricaemia-induced renal disease is a possible complication of gout. Also, tophi may become inflamed, exude tophaceous material, or develop secondary infection.
First acute attacks of gout usually completely subside in 3–10 days. However, attacks may recur.
The diagnosis of gout is based on the clinical history and examination. There is no single examination which confirms a diagnosis of gout.
To manage an acute attack of gout:
A nonsteroidal anti-inflammatory drug (NSAID) e.g. diclofenac, should be prescribed as soon as possible and continued until 48 hours after the attack has resolved (a proton pump inhibitor or misoprostol can be co-prescribed for gastric protection, if necessary).
If NSAIDs are unsuitable, colchicine is an option.
If colchicine is unsuitable, systemic corticosteroids can be considered.
Paracetamol (with or without codeine) should be used if NSAIDs, colchicine, and corticosteroids are all unsuitable.
Appropriate self-care advice should be given (e.g. rest and keeping the joint in a cool environment by avoiding clothing and using an ice pack).
Appropriate life-style advice should be provided (e.g. weight loss and smoking cessation).
If there is no improvement in symptoms after 2–3 days:
The diagnosis should be reviewed.
Compliance with medications and self-care strategies should be checked.
Medication can be increased to the maximum dose.
To prevent an attack of gout:
Allopurinol should be prescribed — after two or more attacks of gout within a year or after the first attack in people at higher risk with one or more tophi, X-ray features of gouty arthritis, renal impairment, known uric acid stones, or on long-term diuretic medication.
Febuxostat can be considered as second-line therapy if allopurinol is not tolerated or contraindicated.
Co-prescription of a low dose of an NSAID or low-dose colchicine may prevent acute attacks of gout during urate lowering treatment with allopurinol or febuxostat.
Allopurinol or febuxostat should be started 1-2 weeks after the inflammation has settled, as the drug may precipitate further attacks.
Advice should be sought from a specialist if:
The diagnosis is uncertain.
Gout occurs during pregnancy or in a person under 25 years of age.
Complications are present.
The person is at risk of adverse effects of drug treatment.
Gout: Guidance FeedbackThe most relevant search results for Gout from producers of guidance information.
Information for the public
Gout: Information for the public FeedbackThe most relevant search results for Gout, from Department of Health accredited producers of patient information.
Gout: Medicines FeedbackAppropriate medicines information for Gout supplied by Datapharm, a leading source of trusted, credible information about medicines.
Gout - Medicines Information
- Adenuric (a brand of Febuxostat)
- Diclofenac potassium
- Diclofenac sodium
- Dicloflex (a brand of Diclofenac Sodium)
- Diclomax (a brand of Diclofenac Sodium)
- Econac (a brand of Diclofenac Sodium)
- Etoricoxib (a generic version of Arcoxia)
- Ketocid (a brand of Ketoprofen)
- Ketovail (a brand of Ketoprofen)
- Motifene (a brand of Diclofenac Sodium)
- Orudis (a brand of Ketoprofen)
- Oruvail (a brand of Ketoprofen)
- Voltarol (a brand of Diclofenac Sodium)
- Voltarol Dispersible (a brand of Diclofenac Sodium)
- Voltarol Rapid (a brand of Diclofenac Potassium)
- Zyloric (a brand of Allopurinol)
- Results are currently sorted by relevance (Sort results by: date)
- Results 1 - 10 (of 36)
Scottish Intercollegiate Guidelines Network, 01 November 2008
...any of these treatments. 4.11 HEaRT faIlURE aND GOUT Loop diuretics can cause an elevated urate level and may precipitate gout.90 No evidence was identified on how best to treat gout in patients with heart failure. Current practice in...
Scottish Intercollegiate Guidelines Network, 01 February 2007
Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement
...Unmet need for allopurinol in thiazide users Gout - 1 11 (9%) MS3: Use of thiazides in CKD Renal...diuretic S8 High-risk use without allopurinol - Gout (MS1) 32. (N) Patient with a history of gout and treated with a thiazide diuretic - is not prescribed allopurinol...
09 February 2012 - Publisher: BMC Clinical Pharmacology - Publication type: Medicines Management
...calcium channel blocker without diagnosis of heart failure • Reconsider indication for thiazides if there is a diagnosis of gout Anticoagulant use (use related to heart disease or stroke prevention) • inr , 2.5 target is not reached • Absence of gastric...
06 February 2014 - Publisher: Patient Preference and Adherence - Publication type: Medicines Management
Medicines and Healthcare products Regulatory Agency, 01 October 2007
Medicines and Healthcare products Regulatory Agency, 07 May 2008
BackgroundAnimal models of traumatic brain injury suggest that induced normothermia (36.5 or 37 ºC), compared to induced hyperthermia (39 ºC), improves histopathological and neurobehavioural outcomes. Observational clinical studies of patients with
Cochrane Database of Systematic Reviews, 19 August 2014 - Publisher: John Wiley & Sons, Ltd
BackgroundAmyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is the most common neurodegenerative disorder of the motor system in adults. Pain in ALS is a frequent symptom especially in the later stages of disease and can
Cochrane Database of Systematic Reviews, 05 June 2013 - Publisher: John Wiley & Sons, Ltd
BackgroundNon-steroidal anti-inflammatory drugs (NSAIDs) have been widely used for the treatment of pain and fever associated with the common cold. However, there is no systematic review to assess the effects of NSAIDs in treating the common
Cochrane Database of Systematic Reviews, 04 June 2013 - Publisher: John Wiley & Sons, Ltd
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease
BackgroundAlzheimers disease (AD) is the most common form of dementia. The incidence of AD rises exponentially with age and its prevalence will increase significantly worldwide in the next few decades. Inflammatory processes have been suspected in
Cochrane Database of Systematic Reviews, 15 February 2012 - Publisher: John Wiley & Sons, Ltd
Searches related to “Gout”
Select one of the 'BNF/BNFc section' options below to narrow your search
- Areas of interest
- Types of information
Start typing a Source name to narrow your search, or select one or more from the list
- British National Formulary - BNF (2)
- Clinical Knowledge Summaries - CKS (2)
- Cochrane Database of Systematic Reviews (11)
- electronic Medicines Compendium - eMC (2)
- Medicines and Healthcare products Regulatory Agency - MHRA(2)
- NHS Choices(1)
- NIHR Journals Library - Health Technology Assessment(3)
- Patient UK(1)
- Scottish Intercollegiate Guidelines Network - SIGN (2)
Medicines and devices
Start typing a Medicine or device name to narrow your search, or select one or more from the A-Z list
- Calcium phosphate(7)
- Certolizumab pegol(10)
- Diclofenac potassium(16)
- Diclofenac sodium(12)
- Fish oil(7)
- Folic acid(10)
- Influenza vaccine(9)
- Insulin glargine(11)
- Interferon alfa-2a(6)
- Interferon alfa-2b(13)
- Irbesartan + hydrochlorothiazide(9)
- Losartan + hydrochlorothiazide(8)
- Mefenamic acid(13)
- Mycophenolate mofetil(61)
- Peginterferon alfa-2a(10)
- Peginterferon alfa-2b(13)
- Salicylic acid(4)
- Sodium chloride(5)
- Tranexamic acid(6)
- Triamcinolone acetonide(8)
- Valsartan + hydrochlorothiazide(15)
- Clear all filters